Skip to content

Enovis ENOV Additional Paid-In Capital

Additional Paid-In Capital at other companies

Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$10.2B+1.1%
ESAB logo
ESABESAB
$1.91B+0.2%
Globus Medical logo
Globus MedicalGMED
$3.21B+5.0%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$3.9B+1.2%
Encompass Health Corporation logo
Encompass Health CorporationEHC
$1.87B+1.2%
Avanos Medical logo
Avanos MedicalAVNS
$1.7B+0.8%

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-40.2%
Enterprise value$2.55B-25.8%
P/S0.5×-0.4×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's additional paid-in capital?
Enovis (ENOV) reported additional paid-in capital of $3.06B in Q1 2026.
How has Enovis's additional paid-in capital changed year-over-year?
Enovis's additional paid-in capital increased by 1.2% year-over-year, from $3.02B to $3.06B.
What is the long-term trend for Enovis's additional paid-in capital?
Over 5 years (2020 to 2025), Enovis's additional paid-in capital has grown at a -2.6% compound annual growth rate (CAGR), from $3.48B to $3.05B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.